Kezar Life Sciences Inc (NASDAQ:KZR)
| 3.13 Delayed Data As of Mar 31 |  -0.035 / -1.11%Today’s Change | 3.09 Today|||52-Week Range 17.80 | -55.61% Year-to-Date |
Latest KZR News | Press Releases
No recent news for Kezar Life Sciences Inc.
Today’s Trading
| Previous close | 3.16 |
| Today’s open | 3.21 |
| Day’s range | 3.09 - 3.28 |
| Volume | 77,604 |
| Average volume (3 months) | 770,719 |
| Market cap | $220.9M |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +2.18% |
| Earnings growth (this year) | -23.27% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| URGNUrogen Pharma Ltd | +0.86 | +10.26% |
| RIGLRigel Pharmaceutical... | -0.02 | -1.49% |
| SELBSelecta Biosciences ... | +0.05 | +3.73% |
| KMDAKamada Ltd | 0.00 | 0.00% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$68.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
